Category: Pharma Industry

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

June 6, 2024 William Newton, Associate Editor/Senior Writer Views

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.

A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

June 6, 2024 Rich Daly, Editor in Chief Views

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.

Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novartis Follows PhRMA in Seeking to Block Mississippi 340B Contract Pharmacy Law

June 6, 2024 Rich Daly, Editor in Chief Views

Drugmaker Novartis has filed the second lawsuit challenging Mississippi's 340B contract pharmacy access law.

Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BMS Requires Re-Designation of 340B Contract Pharmacies and New Requirements Intended to Prevent Alternative Distribution Models

June 6, 2024 Rich Daly, Editor in Chief Views

Drug manufacturer BMS updated its 340B contract pharmacy restrictions to require pharmacies to re-register by June 21 and add additional requirements.

Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sobi Becomes 34th Drugmaker to Implement Contract Pharmacy Restrictions, Exelixis Tightens Contract Pharmacy Policy

June 6, 2024 Shannon Young, Associate Editor/Senior Writer Views

California-based Exelixis, a specialty manufacturer with two high-priced drug products on the market, announced it is further restricting contract pharmacy access to 340B hospitals in a May 31 letter published on 340B ESP.

Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

June 4, 2024 William Newton, Associate Editor/Senior Writer Views

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.

340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Vertex is First to Offer Contract Pharmacy Policy Exemptions to Several States; GSK Restores Discounts To WV Providers

June 4, 2024 Rich Daly, Editor in Chief Views

Drugmaker Vertex implemented 340B contract pharmacy restrictions but exempted the six states with laws prohibiting such policies.

Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UCB is 26th Drugmaker to Exempt Arkansas Providers from Contract Pharmacy Restrictions

June 4, 2024 Rich Daly, Editor in Chief Views

Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions.

Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sandoz Adds Drug to 340B Contract Pharmacy Restrictions

June 4, 2024 Rich Daly, Editor in Chief Views

Drugmaker Sandoz updated its 340B contract pharmacy restrictions to include a new medication.

Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bayer Adds Prostate Cancer Drug to Contract Pharmacy Restrictions

May 29, 2024 Rich Daly, Editor in Chief Views

Bayer added a previously excluded drug to its list of products that face contract pharmacy restrictions.

Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live